Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.
Press releases published on May 8, 2025
Xunlei Limited Schedules 2025 Unaudited First Quarter Earnings Release on May 15, 2025
GlobeNewswire
·
May 8, 2025
SHENZHEN, China, May 08, 2025 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (NASDAQ: XNET), a leading technology company providing distributed cloud services in China, today announced that it plans to release its unaudited financial …
AskBio Announces 15 Presentations at American Society of Gene and Cell Therapy 28th Annual Meeting
GlobeNewswire
·
May 8, 2025
Research Triangle Park, N.C., May 08, 2025 (GLOBE NEWSWIRE) -- Three oral and 12 poster presentations demonstrate breadth and progress of AskBio’s gene therapy research and development activities, as well as advancements in manufacturing capabilities …
All Pro Capital Expands to Kansas City with New Market Executive Matt Jennings
GlobeNewswire
·
May 8, 2025
Colorado Springs, CO, May 08, 2025 (GLOBE NEWSWIRE) -- All Pro Capital is proud to announce the opening of its new Kansas City private equity real estate investments office and the appointment of Kansas native Matt Jennings as Market Executive. This …
PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide
GlobeNewswire
·
May 8, 2025
Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research …
Kamari Pharma Announces Presentations at the 82nd Annual Meeting of the Society for Investigative Dermatology and the International Pachyonychia Congenita Consortium Symposium
GlobeNewswire
·
May 8, 2025
Preclinical results presented demonstrate KM-023 is a highly effective and selective oral TRPV3 inhibitor KM-023 normalized cells proliferation and differentiation in 3D pachyonychia congenita skin model and significantly reduced itch behavior and …
Altimmune Presents New Analyses Predicting High Rates of MASH Resolution on Biopsy following Pemvidutide Treatment at the EASL International Liver Congress™
GlobeNewswire
·
May 8, 2025
GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing next-generation peptide-based therapeutics for liver and cardiometabolic diseases, today announced the …
Palvella Therapeutics to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025
GlobeNewswire
·
May 8, 2025
WAYNE, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic …
Warner Music Group Corp. Reports Results for Fiscal Second Quarter Ended March 31, 2025
GlobeNewswire
·
May 8, 2025
Financial Highlights Q2 Performance Driven by Revenue Growth Across Recorded Music and Music Publishing Cost Savings Plans on Track, With Reinvestment Initiatives Accelerating Year-to-Date Operating Cash Flow and Free Cash Flow Increased by 53% and 59%, …
Caliber Announces First Quarter 2025 Earnings Release & Conference Call
GlobeNewswire
·
May 8, 2025
SCOTTSDALE, Ariz., May 08, 2025 (GLOBE NEWSWIRE) -- Caliber (NASDAQ: CWD), a real estate investor, developer, and manager, today announced that it will release its first quarter 2025 financial results after the close of the market on Thursday, May 15, 2025 …
American Tungsten Corp. Announces Addition to Board of Directors
GlobeNewswire
·
May 8, 2025
Vancouver, BC, May 08, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) announces today the appointment of James (Jim) Whittaker to the Board of Directors of the Company (the “Board …
Purple Garden Empowers Users With Trusted Psychic Guidance
GlobeNewswire
·
May 8, 2025
San Francisco, CA, May 08, 2025 (GLOBE NEWSWIRE) -- Purple Garden is a popular online platform that offers psychic readings to customers anytime and anywhere. The platform has been operating for several years and is considered an industry leader in online …
Dada to Hold Extraordinary General Meeting of Shareholders
GlobeNewswire
·
May 8, 2025
SHANGHAI, China, May 08, 2025 (GLOBE NEWSWIRE) -- Dada Nexus Limited (NASDAQ: DADA, “Dada” or the “Company”), China’s leading local on-demand retail and delivery platform, today announced that it has called an extraordinary general meeting of shareholders …
Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
GlobeNewswire
·
May 8, 2025
ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS …
Wellgistics Health Secures $50M Credit Facility and Launches XRP-Powered Payment Initiative
GlobeNewswire
·
May 8, 2025
Tampa, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX), a technology-first pharmaceutical distribution and healthcare infrastructure company, today announced a new initiative to pioneer the use of XRP, a blockchain-based …
BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025
GlobeNewswire
·
May 8, 2025
NESS ZIONA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that …
Seamless Therapeutics Expands Board of Directors with Appointment of Alvin Shih
GlobeNewswire
·
May 8, 2025
Dresden, Germany, and Lexington, MA, May 8, 2025 – Seamless Therapeutics, today announced the appointment of Alvin Shih, M.D., M.B.A., as an Independent Director to its Board. Dr. Shih is an experienced drug developer and physician with a track record of …
ProQR Announces First Quarter 2025 Operating and Financial Results
GlobeNewswire
·
May 8, 2025
Axiomer™ ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened leadership with appointments of Chief Financial Officer …
Plus Therapeutics to Participate in the D. Boral Capital Inaugural Global Conference
GlobeNewswire
·
May 8, 2025
HOUSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …
OLYMPIC LEGEND SCOTT HAMILTON TO HEADLINE AT ORIGENCE’S LENDING TECH LIVE ‘25
GlobeNewswire
·
May 8, 2025
Irvine, California, May 08, 2025 (GLOBE NEWSWIRE) -- Origence, a leading provider of lending technology solutions, announced Olympic icon Scott Hamilton as a keynote speaker for its Lending Tech Live ’25 conference, scheduled for June 16–18, 2025, at the …
Surge Copper Delivers Geotechnical Results Supporting Pit Design and Resource Growth at Berg
GlobeNewswire
·
May 8, 2025
PFS-level geotechnical program completed under budget; results support steeper pit walls, lower strip ratio, and highlight resource expansion potential Vancouver, British Columbia, May 08, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: …